Boston Scientific Balance Sheet Health
Financial Health criteria checks 4/6
Boston Scientific has a total shareholder equity of $19.5B and total debt of $9.6B, which brings its debt-to-equity ratio to 49%. Its total assets and total liabilities are $35.1B and $15.6B respectively. Boston Scientific's EBIT is $2.5B making its interest coverage ratio 10.3. It has cash and short-term investments of $865.0M.
Key information
49.0%
Debt to equity ratio
US$9.57b
Debt
Interest coverage ratio | 10.3x |
Cash | US$865.00m |
Equity | US$19.53b |
Total liabilities | US$15.61b |
Total assets | US$35.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0HOY's short term assets ($6.5B) exceed its short term liabilities ($4.9B).
Long Term Liabilities: 0HOY's short term assets ($6.5B) do not cover its long term liabilities ($10.7B).
Debt to Equity History and Analysis
Debt Level: 0HOY's net debt to equity ratio (44.6%) is considered high.
Reducing Debt: 0HOY's debt to equity ratio has reduced from 99.9% to 49% over the past 5 years.
Debt Coverage: 0HOY's debt is well covered by operating cash flow (26.2%).
Interest Coverage: 0HOY's interest payments on its debt are well covered by EBIT (10.3x coverage).